Our final day will discuss the direction pre and probiotic research could take as we look to the future, discussing how companies might continue to innovate in this field, and how to effectively communicate ground-breaking research and new found benefits within the boundaries of regulations.
Key areas of discussion will include the popularity of personalised nutrition and health tech, the increased awareness of immunity created by COVID-19, and how recent changes in legislation could impact the EU market.
